Idiopathic pulmonary fibrosis

A. B. Thompson; J. R. Spurzem; S. I. Rennard

Idiopathic pulmonary fibrosis

A. B. Thompson, J. R. Spurzem, S. I. Rennard

Research output: Contribution to journal › Review article › peer-review

Abstract

Idiopathic pulmonary fibrosis (IPF) is a distinct clinicopathologic entity with characteristic physical findings, radiographic changes, and physiologic abnormalities. The histopathology of IPF is now understood to represent a spectrum of inflammatory changes that may have prognostic significance. In spite of significant advances in the understanding of the pathogenesis of IPF, there is still much controversy regarding assessment of disease activity and therapy. Within the context of these controversies, a therapeutic paradigm is suggested.

Original language	English (US)
Pages (from-to)	401-419
Number of pages	19
Journal	Immunology and Allergy Clinics of North America
Volume	12
Issue number	2
State	Published - 1992

ASJC Scopus subject areas

Immunology and Allergy
Immunology

Fingerprint Dive into the research topics of 'Idiopathic pulmonary fibrosis'. Together they form a unique fingerprint.

Cite this

@article{2a634b905c1d44b0b627330d7ffa36ac,

title = "Idiopathic pulmonary fibrosis",

abstract = "Idiopathic pulmonary fibrosis (IPF) is a distinct clinicopathologic entity with characteristic physical findings, radiographic changes, and physiologic abnormalities. The histopathology of IPF is now understood to represent a spectrum of inflammatory changes that may have prognostic significance. In spite of significant advances in the understanding of the pathogenesis of IPF, there is still much controversy regarding assessment of disease activity and therapy. Within the context of these controversies, a therapeutic paradigm is suggested.",

author = "Thompson, {A. B.} and Spurzem, {J. R.} and Rennard, {S. I.}",

year = "1992",

language = "English (US)",

volume = "12",

pages = "401--419",

journal = "Immunology and Allergy Clinics of North America",

issn = "0889-8561",

publisher = "W.B. Saunders Ltd",

number = "2",

}

TY - JOUR

T1 - Idiopathic pulmonary fibrosis

AU - Thompson, A. B.

AU - Spurzem, J. R.

AU - Rennard, S. I.

PY - 1992

Y1 - 1992

N2 - Idiopathic pulmonary fibrosis (IPF) is a distinct clinicopathologic entity with characteristic physical findings, radiographic changes, and physiologic abnormalities. The histopathology of IPF is now understood to represent a spectrum of inflammatory changes that may have prognostic significance. In spite of significant advances in the understanding of the pathogenesis of IPF, there is still much controversy regarding assessment of disease activity and therapy. Within the context of these controversies, a therapeutic paradigm is suggested.

AB - Idiopathic pulmonary fibrosis (IPF) is a distinct clinicopathologic entity with characteristic physical findings, radiographic changes, and physiologic abnormalities. The histopathology of IPF is now understood to represent a spectrum of inflammatory changes that may have prognostic significance. In spite of significant advances in the understanding of the pathogenesis of IPF, there is still much controversy regarding assessment of disease activity and therapy. Within the context of these controversies, a therapeutic paradigm is suggested.

UR - http://www.scopus.com/inward/record.url?scp=0026561264&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026561264&partnerID=8YFLogxK

M3 - Review article

AN - SCOPUS:0026561264

VL - 12

SP - 401

EP - 419

JO - Immunology and Allergy Clinics of North America

JF - Immunology and Allergy Clinics of North America

SN - 0889-8561

IS - 2

ER -

Idiopathic pulmonary fibrosis

Abstract

ASJC Scopus subject areas

Other files and links

Cite this